Results

Total Results: 475 records

Showing results for "gender".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-table-B-1-observational-studies.xlsx
    March 20, 2021 - Definition Negative Cohort Definition Age: Mean (SD) Years or Median (IQR) Race Stratified, N (%) Male Sex/Gender … ages NR for both care homes NR n/N (%) Care home A: 13/46 (26.3) Care home L: 21/57 (36.8*) Staff gender … Geneva and their households Children 5–12 years old Ab+ Two negative serology propensity matched (age, gender
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-evidence-heart-disease.pdf
    October 01, 2022 - setting, study design, study dates, sample size, follow-up duration, patient characteristics (age, gender … N=8307 OMT: N=8136 Diagnosis: chronic coronary syndrome Age: Mean range: 60 to 80 years Gender … N=5,575 OMT: N=5,569 Diagnosis: stable obstructive CAD Age: Mean range: 62 to 65 years GenderGender: Range: 69% to 95% male Intervention/Comparators: PCI vs. MT CABG vs. MT PCI vs. … OMT: N=826 Diagnosis: coronary CTO Age: Mean range: 57 to 65 years Gender: Range: 82% to 89%
  3. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol-amended.pdf
    February 07, 2025 - Synthes is “We do not anticipate social determinants of health (e.g., race and ethnicity, gender … of interest” These terms were removed to comply with Executive Order Defending Women from Gender … Plus framework (which includes Place; Race/ethnicity/culture/la nguage; Occupation; Out of Work, Gender … provide clarity” These terms were removed to comply with Executive Order Defending Women from Gender
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol-amendment.pdf
    May 02, 2025 - Data Synthesis “We do not anticipate social determinants of health (e.g., race and ethnicity, gender … of interest” These terms were removed to comply with Executive Order Defending Women from Gender … PROGRESS-Plus framework (which includes Place; Race/ethnicity/culture/la nguage; Occupation; Out of Work, Gender … provide clarity” These terms were removed to comply with Executive Order Defending Women from Gender
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability-quiz.ppt
    May 29, 2025 - Differences in gender and age between the study population and the general population Use of a surrogate
  6. effectivehealthcare.ahrq.gov/sites/default/files/assessing-applicability-quiz.ppt
    May 29, 2025 - Differences in gender and age between the study population and the general population Use of a surrogate
  7. effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-treatment-ssri_surveillance.pdf
    January 01, 2013 - therapies compare in different populations (e.g., different depressive diagnoses, disease severity, age, gender … The effects of baseline severity, previous treatment failure, age, gender, and race were not sufficiently … therapies compare in different populations (e.g., different depressive diagnoses, disease severity, age, gender … The  effects  of  baseline   severity,  previous  treatment  failure,  age,   gender
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-fracture-pain_clinician.pdf
    May 01, 2011 - research studies are needed that are large enough for statistical analysis of subgroups (by age, gender
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
    January 01, 2013 - Do the effect estimates of clinical cardiovascular outcomes vary by age, ethnicity, gender, or health … Do the effect estimates of intermediate cardiovascular outcomes vary by age, ethnicity, gender, or health … Do the effect estimates of pharmacokinetic outcomes vary by age, ethnicity, gender, or health status? … Do the effect estimates of clinical cardiovascular outcomes vary by age, ethnicity, gender, or health … Do the effect estimates of pharmacokinetic outcomes vary by age, ethnicity, gender, or health status?
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-275-people-with-disabilities-disposition-comments.pdf
    September 16, 2024 - descriptions generally do not note where the studies were conducted or the characteristics (including gender … your language choices around disability, it may be worth considering adding a footnote about sex and gender … At a minimum, an acknowledgement in a We have made edits to change gender-specific terms (e.g., “women … with disabilities”) to gender-neutral terms (e.g. … We have also added a footnote to Table 1 indicating that we have used gender-specific terms (e.g.,
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F-5.xlsx
    January 01, 2022 - Pain intensity index (0-100 scale; converted to 0-10 scale) 4.4 (SD 1.46) Propensity matched on age, gender … B Average 24-h PIX (0 to 100 VAS): 43.3 (14.0) vs. 43.1 (14.0) Overall mean: 43.2 (SD 14.0) Age, gender
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-table-F5.xlsx
    January 01, 2022 - Pain intensity index (0-100 scale; converted to 0-10 scale) 4.4 (SD 1.46) Propensity matched on age, gender … B Average 24-h PIX (0 to 100 VAS): 43.3 (14.0) vs. 43.1 (14.0) Overall mean: 43.2 (SD 14.0) Age, gender
  13. Slide 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/johnson_-ahrq-mcda-presentation.pdf
    August 27, 2012 - Process factors – Health-Care Setting – Physician interactions  Personal factors – Age, gender
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-table-e5.xlsx
    January 01, 2024 - ]): A: 4.13 (2.93-5.65); B: 3.96 (1.77-5.45); C: 4.56 (3.27-6.20) Univariate analysis for age, BMI, gender … Pain intensity index (0-100 scale; converted to 0-10 scale) 4.4 (SD 1.46) Propensity matched on age, gender … B Average 24-h PIX (0 to 100 VAS): 43.3 (14.0) vs. 43.1 (14.0) Overall mean: 43.2 (SD 14.0) Age, gender
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-cardiovascular-elderly_research.pdf
    February 01, 2009 - Age, gender, and race. Comorbidities. … % of Conventional % of Atypical APM Users APM Users Age (mean): 83.2 83.5 Gender … 1.20 (1.03, 1.39) 1.10 (0.98, 1.24) 1.06 (0.96, 1.17) *Controlled for calendar year, age, gender
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear-surveillance-140925.pdf
    February 01, 2014 - 1 • Key question # 6: Which demographic (e.g., age, gender, ethnicity, comorbidities … fatty infiltration (Goutallier 1.3 vs 0.3, p=0.01).33 One Signal A third cohort study found that gender … repair the failure rate was significantly higher in patients with lower BMD (p<0.001); female gender … Key Question 6: Which demographic (e.g., age, gender, ethnicity, comorbidities, workers‘ compensation … aggravation, smoking, diabetes mellitus female gender (P = .03); larger tear size (P<.001); higher
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_disposition-comments.pdf
    June 12, 2012 - There are numerous gender comparisons of prognosis in very large registries often including more than … Also, based on my knowledge of the literature, there is no known gender difference with respect to any … recommended methods, such as Diamond- Forrester or CASS study criteria (where pain type, age, and gender … No other gender differences were noted in diagnostic accuracy. … Gender-specific issues such as symptom and test-related office visits, downstream testing that can be
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_surveillance.pdf
    August 01, 2012 - characteristics of interest include, but are not limited to, age (prepubertal, pubertal, postpubertal), gender … In five controlled trials, rhGH therapy did not improve sexual maturation regardless of gender. … In one controlled trial, mean Tanner stage improved regardless of gender, and in an analysis of three … New Evidence: Gender: While trials were conducted predominantly in males, the impact … of gender on outcomes of rhGH therapy could be evaluated in one pooled analysis.
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
    November 01, 2010 - significantly in subgroups of people who are easily identified by one or more of the following factors: age, gender … CVD]), vascular risk factors (e.g., hypertension, diabetes, obesity, hyperlipidemia, smoking, male gender … CVD), vascular risk factors (e.g., hypertension, diabetes, obesity, hyperlipidemia, smoking, male gender … CVD), vascular risk factors (e.g., hypertension, diabetes, obesity, hyperlipidemia, smoking, male gender
  20. effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
    March 01, 2010 - In patients with cystic fibrosis and relevant subgroups based on gender, age, baseline clinical status … In patients with cystic fibrosis and relevant subgroups based on gender, age, baseline clinical status … characteristics of interest include, but are not limited to, age (prepubertal, pubertal, postpubertal); gender … characteristics of interest include, but are not limited to, age (prepubertal, pubertal, postpubertal); gender

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: